{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T17:41:22Z","timestamp":1768930882792,"version":"3.49.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,19]]},"DOI":"10.7759\/cureus.101878","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T03:24:57Z","timestamp":1768879497000},"source":"Crossref","is-referenced-by-count":0,"title":["When the Infection Clears but Inflammation Persists: A Case of Chlamydia-Associated Reactive Arthritis Requiring Disease-Modifying Antirheumatic Drug (DMARD) Therapy"],"prefix":"10.7759","author":[{"given":"Zaineb","family":"Khawar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ifunanyachukwu","family":"Umeozor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arsany","family":"Anis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2011.05.001","article-title":"Chlamydia-induced reactive arthritis: hidden in plain sight?","volume":"25","author":"Carter JD","year":"2011","unstructured":"Carter JD, Inman RD. Chlamydia-induced reactive arthritis: hidden in plain sight?. Best Pract Res Clin Rheumatol. 2011, 25:359-74. 10.1016\/j.berh.2011.05.001","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2011.01.018","article-title":"Reactive arthritis","volume":"25","author":"Hannu T","year":"2011","unstructured":"Hannu T. Reactive arthritis. Best Pract Res Clin Rheumatol. 2011, 25:347-57. 10.1016\/j.berh.2011.01.018","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4997\/JRCPE.2021.319","article-title":"Reactive arthritis: a clinical review","volume":"51","author":"Jubber A","year":"2021","unstructured":"Jubber A, Moorthy A. Reactive arthritis: a clinical review. J R Coll Physicians Edinb. 2021, 51:288-97. 10.4997\/JRCPE.2021.319","journal-title":"J R Coll Physicians Edinb"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/tre.501","article-title":"Reactive arthritis: can\u2019t see, can\u2019t pee, can\u2019t climb a tree...","volume":"7","author":"Szamocki S","year":"2016","unstructured":"Szamocki S, Martyn-Hemphill C, Green JS. Reactive arthritis: can\u2019t see, can\u2019t pee, can\u2019t climb a tree.... Trends Urol Men's Health. 2016, 7:17-20. 10.1002\/tre.501","journal-title":"Trends Urol Men's Health"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00393-024-01594-9","article-title":"Reactive arthritis (Article in German)","volume":"84","author":"Rihl M","year":"2025","unstructured":"Rihl M, Kuipers JG. Reactive arthritis (Article in German). Z Rheumatol. 2025, 84:259-67. 10.1007\/s00393-024-01594-9","journal-title":"Z Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.044966","article-title":"Persistent infection of Chlamydia in reactive arthritis","volume":"65","author":"Rihl M","year":"2006","unstructured":"Rihl M, K\u00f6hler L, Klos A, Zeidler H. Persistent infection of Chlamydia in reactive arthritis. Ann Rheum Dis. 2006, 65:281-4. 10.1136\/ard.2005.044966","journal-title":"Ann Rheum Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/01.JAA.0000558320.47868.2f","article-title":"An overview of reactive arthritis","volume":"32","author":"Pennisi M","year":"2019","unstructured":"Pennisi M, Perdue J, Roulston T, Nicholas J, Schmidt E, Rolfs J. An overview of reactive arthritis. JAAPA. 2019, 32:25-8. 10.1097\/01.JAA.0000558320.47868.2f","journal-title":"JAAPA"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.17.2.348-369.2004","article-title":"HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations","volume":"17","author":"Colmegna I","year":"2004","unstructured":"Colmegna I, Cuchacovich R, Espinoza LR. HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations. Clin Microbiol Rev. 2004, 17:348-69. 10.1128\/CMR.17.2.348-369.2004","journal-title":"Clin Microbiol Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20191927","article-title":"Treatment of reactive arthritis with biological agents: a review","volume":"40","author":"Zeng H","year":"2020","unstructured":"Zeng H, Luo B, Zhang Y, Xie Z, Ye Z. Treatment of reactive arthritis with biological agents: a review. Biosci Rep. 2020, 40:BSR20191927. 10.1042\/BSR20191927","journal-title":"Biosci Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2217\/ijr.12.65","article-title":"The molecular basis for disease phenotype in chronic Chlamydia-induced arthritis","volume":"7","author":"Carter JD","year":"2012","unstructured":"Carter JD, Gerard HC, Whittum-Hudson JA, Hudson AP. The molecular basis for disease phenotype in chronic Chlamydia-induced arthritis. Int J Clin Rheumtol. 2012, 7:627-40. 10.2217\/ijr.12.65","journal-title":"Int J Clin Rheumtol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200004)43:4<720::AID-ANR2>3.0.CO;2-8","article-title":"Report on the Fourth International Workshop on Reactive Arthritis","volume":"43","author":"Sieper J","year":"2000","unstructured":"Sieper J, Braun J, Kingsley GH. Report on the Fourth International Workshop on Reactive Arthritis. Arthritis Rheum. 2000, 43:720-34. 10.1002\/1529-0131(200004)43:4&lt;720::AID-ANR2&gt;3.0.CO;2-8","journal-title":"Arthritis Rheum"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-021-01018-6","article-title":"Reactive arthritis update: spotlight on new and rare infectious agents implicated as pathogens","volume":"23","author":"Zeidler H","year":"2021","unstructured":"Zeidler H, Hudson AP. Reactive arthritis update: spotlight on new and rare infectious agents implicated as pathogens. Curr Rheumatol Rep. 2021, 23:53. 10.1007\/s11926-021-01018-6","journal-title":"Curr Rheumatol Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/ard.55.8.564","article-title":"Third International Workshop on Reactive Arthritis. 23-26 September 1995, Berlin, Germany. Report and abstracts","volume":"55","author":"Kingsley G","year":"1996","unstructured":"Kingsley G, Sieper J. Third International Workshop on Reactive Arthritis. 23-26 September 1995, Berlin, Germany. Report and abstracts. Ann Rheum Dis. 1996, 55:564-84. 10.1136\/ard.55.8.564","journal-title":"Ann Rheum Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/bor.0b013e32832af481","article-title":"MRI in ankylosing spondylitis","volume":"21","author":"Maksymowych WP","year":"2009","unstructured":"Maksymowych WP. MRI in ankylosing spondylitis. Curr Opin Rheumatol. 2009, 21:313-7. 10.1097\/bor.0b013e32832af481","journal-title":"Curr Opin Rheumatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s40588-020-00152-6","article-title":"Reactive arthritis: update","volume":"7","author":"Bentaleb I","year":"2020","unstructured":"Bentaleb I, Abdelghani KB, Rostom S, Amine B, Laatar A, Bahiri R. Reactive arthritis: update. Curr Clin Microbiol Rep. 2020, 7:124-32. 10.1007\/s40588-020-00152-6","journal-title":"Curr Clin Microbiol Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/01.rhu.0000217179.21300.82","article-title":"Frequency of HLA-B27 and its alleles in patients with Fiessinger-Leroy-Reiter syndrome: comparison with the frequency in other spondyloarthropathies and a healthy control population\r\nP48","volume":"12","author":"Sampaio-Barros PD","year":"2006","unstructured":"Sampaio-Barros PD, Conde RA, Donadi EA, Bonfiglioli R, Costallat LT, Samara AM, B\u00e9rtolo BM. Frequency of HLA-B27 and its alleles in patients with Fiessinger-Leroy-Reiter syndrome: comparison with the frequency in other spondyloarthropathies and a healthy control population\r\nP48. J Clin Rheumatol. 2006, 12:S15. 10.1097\/01.rhu.0000217179.21300.82","journal-title":"J Clin Rheumatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/art.27394","article-title":"Combination antibiotics as a treatment for chronic Chlamydia-induced reactive arthritis: a double-blind, placebo-controlled, prospective trial","volume":"62","author":"Carter JD","year":"2010","unstructured":"Carter JD, Espinoza LR, Inman RD, et al.. Combination antibiotics as a treatment for chronic Chlamydia-induced reactive arthritis: a double-blind, placebo-controlled, prospective trial. Arthritis Rheum. 2010, 62:1298-307. 10.1002\/art.27394","journal-title":"Arthritis Rheum"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/416925-when-the-infection-clears-but-inflammation-persists-a-case-of-chlamydia-associated-reactive-arthritis-requiring-disease-modifying-antirheumatic-drug-dmard-therapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T03:25:18Z","timestamp":1768879518000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/416925-when-the-infection-clears-but-inflammation-persists-a-case-of-chlamydia-associated-reactive-arthritis-requiring-disease-modifying-antirheumatic-drug-dmard-therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.101878","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,19]]}}}